Spiriva first available therapy in new inhaler technology

inhaler technology spiriva
Inhaler technology that revolutionises how medication is delivered to the lungs is now available in Australia and set to become the delivery platform for a range of inhaled therapies, says Boehringer Ingelheim. Boehringer Ingelheim confirmed that Spiriva (tiotropium bromide 5mg) is the first therapy available in the new Respimat Soft Mist Inhaler and will be

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Women in the dark about their breast cancer risk
Next Pharmacies the top shop for vitamins and minerals: Roy Morgan